Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.02%
1,108.47
+0.24
+0.02%
1,108.231,109.651,115.881,105.59
SIXC
Communications
SIXC
Communications
SIXC
+0.89%
611.04
+5.41
+0.89%
605.63605.63611.67602.96
SIXE
Energy
SIXE
Energy
SIXE
-0.11%
1,208.63
-1.32
-0.11%
1,209.951,210.981,211.681,197.20
SIXI
Industrials
SIXI
Industrials
SIXI
-0.35%
1,752.13
-6.10
-0.35%
1,758.231,759.031,760.641,739.69
SIXM
Financials
SIXM
Financials
SIXM
-0.87%
629.42
-5.52
-0.87%
634.94632.49632.49627.63
SIXR
Staples
SIXR
Staples
SIXR
+0.25%
854.48
+2.11
+0.25%
852.37850.81859.97849.13
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0.82%
217.06
-1.79
-0.82%
218.85218.85218.85215.61
SIXT
Technology
SIXT
Technology
SIXT
+1.15%
3,569.06
+40.57
+1.15%
3,528.493,565.203,578.773,509.18
SIXU
Utilities
SIXU
Utilities
SIXU
-1.05%
905.26
-9.56
-1.05%
914.82910.36910.36897.78
SIXV
Health care
SIXV
Health care
SIXV
+0.78%
1,483.77
+11.50
+0.78%
1,472.271,470.891,484.151,466.47
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.56%
2,404.07
+13.46
+0.56%
2,390.612,387.312,409.702,373.97
CGEM:NASDAQ
Cullinan Therapeutics Inc
$16.04
-0.68%
(-0.11) 1D
May 13, 3:26:15 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CGEM...
Open
$16.00
High
$16.48
Low
$15.66
Mkt. cap
975.03M
Avg. vol.
822.52K
Volume
589.01K
52-wk high
$16.74
52-wk low
$5.68
EPS
-$3.72
Beta
-0.09
Shares outstanding
61.46M
No. of employees
109
News stories
From sources across the web
About Cullinan Therapeutics Inc
CEO-
Employees109
Founded2016
Headquarters-
SectorBiotechnology
Last report
May 7, 2026
Fiscal Period
Q1 2026
EPS / Est. (USD)
-$0.75 / -$0.84
+11.06%beat
Revenue / Est. (USD)
- / 0.00
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
61.03M
41.97M
42.94M
42.12M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14.77M
13.63M
12.31M
11.57M
Operating expense
75.80M
55.60M
55.26M
53.70M
Total operating expenses
75.80M
55.60M
55.26M
53.70M
Operating income
-75.80M
-55.60M
-55.26M
-53.70M
Other non operating income
-181.00K
-108.00K
-69.00K
-62.00K
EBT including unusual items
-70.06M
-50.61M
-50.71M
-49.66M
EBT excluding unusual items
-70.06M
-50.61M
-50.71M
-49.66M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-70.06M
-50.61M
-50.71M
-49.66M
Net profit margin
-
-
-
-
Earnings per share
-1.07
-0.77
-0.77
-0.75
Interest and investment income
5.92M
5.09M
4.62M
4.10M
Interest expense
-
-
-
-
Net interest expenses
5.92M
5.09M
4.62M
4.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
-75.72M
-55.52M
-55.18M
-53.62M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more